|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/12 | |
| A61K 47/10 | |||
| A61K 47/44 | |||
| A61K 31/573 |
| (11) | Patento numeris | 3389631 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16810067.5 |
| Europos patento paraiškos padavimo data | 2016-11-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-10-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-11-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2016/057227 |
| Data | 2016-11-30 |
| (87) | Numeris | WO 2017/103719 |
| Data | 2017-06-22 |
| (30) | Numeris | Data | Šalis |
| 201562267749 P | 2015-12-15 | US |
| (72) |
GAUTHIER, Robert T., US
HAMMER, James D., US
|
| (73) |
Therapeutics, Inc.,
9025 Balboa Avenue, Suite 100, San Diego, CA 92123,
US
|
| (54) | HALOBETASOL FOAM COMPOSITION AND METHOD OF USE THEREOF |
| HALOBETASOL FOAM COMPOSITION AND METHOD OF USE THEREOF |